International Journal of Oncology 2022

4 papers
The 2022 edition of the International Journal of Oncology emphasized research into the molecular drivers of tumor progression and the development of prognostic signatures for advanced visceral malignancies. A significant focus was placed on enhancing translational robustness within preclinical biomedical research, aiming to bridge the gap between laboratory findings and clinical applications. Specific studies published during this year explored the mechanisms of long non-coding RNAs (lncRNAs) in cancer development. This included investigations into how HHLA2 promotes gallbladder cancer through lncRNA H19 and the role of lncRNA 01614 in hyperactivating WNT/β-catenin signaling in pancreatic cancer. Clinical research was also represented by a pilot trial evaluating topical MTS-01 for reducing dermatitis in patients receiving chemoradiotherapy for anal canal carcinoma. Prolific authors contributing to these themes included Deborah E. Citrin, Kevin Camphausen, and Baokang Wu, highlighting a range of studies spanning molecular signaling and supportive care in oncology.

Top Research Directions

The 2 research directions with International Journal of Oncology 2022 papers, ranked by paper count, next to 2020. Share is the fraction of the edition’s papers in the direction.

#Direction20222020Share 2022Share 20202020 rank
1Multicellular Ecosystems and Ecotypes in the Tumor Microenvironment1025.0%0.0%—
2The Limits of Single Cell Line Generalizability1025.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by International Journal of Oncology 2022 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 1 credited papers.

#InstitutionPapersShare20202020 rank
1012sz4c50 1100.0%0—
202yd1yr68 1100.0%0—
3China Medical University 1100.0%0—

Download all institutions as CSV

About this data

Papers. International Journal of Oncology 2022 lists 4 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2020 use shares, since the edition went from 2 to 4 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 4 papers (25.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “International Journal of Oncology 2022”, https://lacuna.tiptreesystems.com/venue/international-journal-of-oncology/2022.

Top Authors

AuthorPapers
Yu Shi1

Papers

Title
HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer
Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal